<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1.0"><!-- Inform modern browsers that this page supports both dark and light color schemes,
  and the page author prefers light. --><meta name="color-scheme" content="dark light"><script>
  // If `prefers-color-scheme` is not supported, fall back to light mode.
  // i.e. In this case, inject the `light` CSS before the others, with
  // no media filter so that it will be downloaded with highest priority.
  if (window.matchMedia("(prefers-color-scheme: dark)").media === "not all") {
    document.documentElement.style.display = "none";
    document.head.insertAdjacentHTML(
      "beforeend",
      "<link id=\"css\" rel=\"stylesheet\" href=\"https://bootswatch.com/3/flatly/bootstrap.css\" onload=\"document.documentElement.style.display = ''\">"
    );
  }
</script><title>Irinotecan / S-1 Toxicity Dataset — dat.roever2022 • metadat</title><!-- jquery --><script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.4.1/jquery.min.js" integrity="sha256-CSXorXvZcTkaix6Yvo6HppcZGetbYMGWSFlBw8HfCJo=" crossorigin="anonymous"></script><!-- Bootstrap --><script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.4.1/js/bootstrap.min.js" integrity="sha256-nuL8/2cJ5NDSSwnKD8VqreErSWHtnEP9E7AySL+1ev4=" crossorigin="anonymous"></script><!-- bootstrap-toc --><link rel="stylesheet" href="../bootstrap-toc.css"><script src="../bootstrap-toc.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous"><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous"><!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- pkgdown --><link href="../pkgdown.css" rel="stylesheet"><script src="../pkgdown.js"></script><!-- docsearch --><script src="../docsearch.js"></script><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/docsearch.js/2.6.3/docsearch.min.css" integrity="sha256-QOSRU/ra9ActyXkIBbiIB144aDBdtvXBcNc3OTNuX/Q=" crossorigin="anonymous"><link href="../docsearch.css" rel="stylesheet"><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/jquery.mark.min.js" integrity="sha256-4HLtjeVgH0eIB3aZ9mLYF6E8oU5chNdjU6p6rrXpl9U=" crossorigin="anonymous"></script><meta property="og:title" content="Irinotecan / S-1 Toxicity Dataset — dat.roever2022"><meta property="og:description" content="12 studies investigating the occurrence of dose limiting toxicities (DLTs) at different doses of a combination therapy of Irinotecan and S-1."><meta name="twitter:card" content="summary_large_image"><meta name="twitter:creator" content="@wviechtb"><meta name="twitter:site" content="@wviechtb"><!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]--><!-- Flatly Theme - Light  --><link id="css-light" rel="stylesheet" href="https://bootswatch.com/3/flatly/bootstrap.css" media="(prefers-color-scheme: light), (prefers-color-scheme: no-preference)"><!-- Darkly Theme - Dark --><link id="css-dark" rel="stylesheet" href="https://bootswatch.com/3/darkly/bootstrap.css" media="(prefers-color-scheme: dark)"><!-- preferably CSS --><link rel="stylesheet" href="../preferably.css"><link id="css-code-light" rel="stylesheet" href="../code-color-scheme-light.css" media="(prefers-color-scheme: light), (prefers-color-scheme: no-preference)"><link id="css-code-dark" rel="stylesheet" href="../code-color-scheme-dark.css" media="(prefers-color-scheme: dark)"><script src="../darkswitch.js"></script></head><body data-spy="scroll" data-target="#toc">


    <div class="container template-reference-topic">
      <header><div class="navbar navbar-default navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false">
        <span class="sr-only">Toggle navigation</span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <span class="navbar-brand">
        <a class="navbar-link" href="../index.html">metadat</a>
        <span class="version label label-default" data-toggle="tooltip" data-placement="bottom" title="">1.5-4</span>
      </span>
    </div>

    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav"><li>
  <a href="../index.html">
    <span class="fa fa-home fa-lg"></span>

  </a>
</li>
<li>
  <a href="../reference/index.html">Datasets / Functions</a>
</li>
<li>
  <a href="../news/index.html">Changelog</a>
</li>
      </ul><ul class="nav navbar-nav navbar-right"><li>
          <a href="#" id="css-toggle-btn">
            <span class="fas fa-adjust fa-lg"></span>
          </a>
        </li>

        <li>
  <a href="https://scholar.social/@wviechtb" class="external-link">Mastodon</a>
</li>
<li>
  <a href="https://github.com/wviechtb/metadat" class="external-link">GitHub</a>
</li>




      </ul><form class="navbar-form navbar-right hidden-xs hidden-sm" role="search">
        <div class="form-group">
          <input type="search" class="form-control" name="search-input" id="search-input" placeholder="Search..." aria-label="Search for..." autocomplete="off"></div>
      </form>

    </div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->



      </header><div class="row">
  <div class="col-md-9 contents">
    <div class="page-header">
    <h1>Irinotecan / S-1 Toxicity Dataset</h1>

    <div class="hidden name"><code>dat.roever2022.Rd</code></div>
    </div>

    <div class="ref-description">
    <p>12 studies investigating the occurrence of dose limiting toxicities (DLTs) at different doses of a combination therapy of Irinotecan and S-1.</p>
    </div>

    <div id="ref-usage">
    <div class="sourceCode"><pre class="sourceCode r"><code><span><span class="va">dat.roever2022</span></span></code></pre></div>
    </div>

    <div id="format">
    <h2>Format</h2>
    <p>The data frame contains the following columns:</p><table class="table table"><tr><td><b>study</b></td><td><code>character</code></td><td>study label</td></tr><tr><td><b>year</b></td><td><code>integer</code></td><td>publication year</td></tr><tr><td><b>dose</b></td><td><code>numeric</code></td><td>dose (\(\mathrm{mg} / \mathrm{m}^2\))</td></tr><tr><td><b>events</b></td><td><code>integer</code></td><td>number of DLTs</td></tr><tr><td><b>total</b></td><td><code>integer</code></td><td>number of patients exposed</td></tr></table></div>
    <div id="details">
    <h2>Details</h2>
    <p>A combination therapy of Irinotecan (a topoisomerase 1 inhibitor) and S-1 (a combination of three pharmacological compounds, namely, tegafur, gimeracil, and oteracil potassium) was tested in advanced colorectal and gastric cancer. This dataset contains data from twelve studies investigating this therapy in a Japanese population; it contains the doses investigated, the numbers of patients treated, and the number of dose-limiting toxicities (DLTs) observed. In general, each study investigated several doses according to some dose-escalation scheme.</p>
    </div>
    <div id="source">
    <h2>Source</h2>
    <p>Ursino, M., Röver, C., Zohar,  S., &amp; Friede T. (2021). Random-effects meta-analysis of phase I dose-finding studies using stochastic process priors. <em>The Annals of Applied Statistics</em>, <b>15</b>(1), 174–193. <a href="https://doi.org/10.1214/20-AOAS1390" class="external-link">https://doi.org/10.1214/20-AOAS1390</a></p>
<p>Röver, C., Ursino, M., Friede, T., &amp; Zohar, S. (2022). A straighforward meta-analysis approach for oncology phase I dose-finding studies. <em>Statistics in Medicine</em>, <b>41</b>(20), 3915–3940. <a href="https://doi.org/10.1002/sim.9484" class="external-link">https://doi.org/10.1002/sim.9484</a></p>
    </div>
    <div id="references">
    <h2>References</h2>
    <p>European Medicines Agency (EMA) (2021). Onivyde pegylated liposomal (irinotecan hydrochloride trihydrate) EPAR summary. <a href="https://www.ema.europa.eu/en/medicines/human/EPAR/onivyde-pegylated-liposomal" class="external-link">https://www.ema.europa.eu/en/medicines/human/EPAR/onivyde-pegylated-liposomal</a></p>
<p>European Medicines Agency (EMA) (2022). Teysuno (tegafur/gimeracil/oteracil) EPAR summary. <a href="https://www.ema.europa.eu/en/medicines/human/EPAR/teysuno" class="external-link">https://www.ema.europa.eu/en/medicines/human/EPAR/teysuno</a></p>
<p>Yamada, Y., Yasui, H., Goto, A., <em>et al.</em> (2003). Phase I study of irinotecan and S-1 combination therapy in patients with metastatic gastric cancer. <em>International Journal of Clinical Oncology</em>, <b>8</b>(6), 374–380. <a href="https://doi.org/10.1007/s10147-003-0359-z" class="external-link">https://doi.org/10.1007/s10147-003-0359-z</a></p>
<p>Takiuchi, H., Narahara, H., Tsujinaka, T., <em>et al.</em> (2005). Phase I study of S-1 combined with irinotecan (CPT-11) in patients with advanced gastric cancer (OGSG 0002). <em>Japanese Journal of Clinical Oncology</em>, <b>35</b>(9), 520–525. <a href="https://doi.org/10.1093/jjco/hyi148" class="external-link">https://doi.org/10.1093/jjco/hyi148</a></p>
<p>Inokuchi, M., Yamashita, T., Yamada, H., <em>et al.</em> (2006). Phase I/II study of S-1 combined with irinotecan for metastatic advanced gastric cancer. <em>British Journal of Cancer</em>, <b>94</b>(8), 11130. <a href="https://doi.org/10.1038/sj.bjc.6603072" class="external-link">https://doi.org/10.1038/sj.bjc.6603072</a></p>
<p>Nakafusa, Y., Tanaka, M., Ohtsuka, T., <em>et al.</em> (2008). Phase I/II study of combination therapy with S-1 and CPT-11 for metastatic colorectal cancer. <em>Molecular Medicine Reports</em>, <b>1</b>(6), 925–930. <a href="https://doi.org/10.3892/mmr_00000051" class="external-link">https://doi.org/10.3892/mmr_00000051</a></p>
<p>Ishimoto, O., Ishida, T., Honda, Y., Munakata, M., &amp; Sugawara, S. (2009). Phase I study of daily S-1 combined with weekly irinotecan in patients with advanced non-small cell lung cancer. <em>International Journal of Clinical Oncology</em>, <b>14</b>(1), 43–47. <a href="https://doi.org/10.1007/s10147-008-0796-9" class="external-link">https://doi.org/10.1007/s10147-008-0796-9</a></p>
<p>Ogata, Y., Sasatomi, T., Akagi, Y., Ishibashi, N., Mori, S., &amp; Shirouzu, K. (2009). Dosage escalation study of S-1 and irinotecan in metronomic chemotherapy against advanced colorectal cancer. <em>The Kurume Medical Journal</em>, <b>56</b>(1+2), 1–7. <a href="https://doi.org/10.2739/kurumemedj.56.1" class="external-link">https://doi.org/10.2739/kurumemedj.56.1</a></p>
<p>Shiozawa, M., Sugano, N., Tsuchida, K., Morinaga, S., Akaike, M., &amp; Sugimasa, Y. (2009). A phase I study of combination therapy with S-1 and irinotecan (CPT-11) in patients with advanced colorectal cancer. <em>Journal of Cancer Research and Clinical Oncology</em>, <b>135</b>(3), 365–370. <a href="https://doi.org/10.1007/s00432-008-0480-5" class="external-link">https://doi.org/10.1007/s00432-008-0480-5</a></p>
<p>Yoshioka, T., Kato, S., Gamoh, M., <em>et al.</em> (2009). Phase I/II study of sequential therapy with irinotecan and S-1 for metastatic colorectal cancer. <em>British Journal of Cancer</em>, <b>101</b>, 1972–1977. <a href="https://doi.org/10.1038/sj.bjc.6605432" class="external-link">https://doi.org/10.1038/sj.bjc.6605432</a></p>
<p>Komatsu, Y., Yuki, S., Fuse, N., <em>et al.</em> (2010). Phase 1/2 clinical study of irinotecan and oral S-1 (IRIS) in patients with advanced gastric cancer. <em>Advances in Therapy</em>, <b>27</b>(7), 483–492. <a href="https://doi.org/10.1007/s12325-010-0037-2" class="external-link">https://doi.org/10.1007/s12325-010-0037-2</a></p>
<p>Kusaba, H., Esaki, T., Futami, K., <em>et al.</em> (2010). Phase I/II study of a 3-week cycle of irinotecan and S-1 in patients with advanced colorectal cancer. <em>Cancer Science</em>, <b>101</b>(12), 2591–2595. <a href="https://doi.org/10.1111/j.1349-7006.2010.01728.x" class="external-link">https://doi.org/10.1111/j.1349-7006.2010.01728.x</a></p>
<p>Yoda, S., Soejima, K., Yasuda, H., <em>et al.</em> (2011). A phase I study of S-1 and irinotecan combination therapy in previously treated advanced non-small cell lung cancer patients. <em>Cancer Chemotherapy and Pharmacology</em>, <b>67</b>(3), 717–722. <a href="https://doi.org/10.1007/s00280-010-1539-y" class="external-link">https://doi.org/10.1007/s00280-010-1539-y</a></p>
<p>Goya, H., Kuraishi, H., Koyama, S., <em>et al.</em> (2012). Phase I/II study of S-1 combined with biweekly irinotecan chemotherapy in previously treated advanced non-small cell lung cancer. <em>Cancer Chemotherapy and Pharmacology</em>, <b>70</b>(5), 691–697. <a href="https://doi.org/10.1007/s00280-012-1957-0" class="external-link">https://doi.org/10.1007/s00280-012-1957-0</a></p>
    </div>
    <div id="see-also">
    <h2>See also</h2>
    <div class="dont-index"><p><code><a href="dat.ursino2021.html">dat.ursino2021</a></code></p></div>
    </div>
    <div id="author">
    <h2>Author</h2>
    <p>Christian Röver, <a href="mailto:christian.roever@med.uni-goettingen.de">christian.roever@med.uni-goettingen.de</a></p>
    </div>
    <div id="concepts">
    <h2>Concepts</h2>
    <p>medicine, oncology, dose-response models</p>
    </div>

    <div id="ref-examples">
    <h2>Examples</h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span class="r-in"><span><span class="co"># show (some) data</span></span></span>
<span class="r-in"><span><span class="fu"><a href="https://rdrr.io/r/utils/head.html" class="external-link">head</a></span><span class="op">(</span><span class="va">dat.roever2022</span>, n<span class="op">=</span><span class="fl">10</span><span class="op">)</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span>       study year dose events total</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 1    Yamada 2003  100      0     3</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 2    Yamada 2003  125      0     3</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 3    Yamada 2003  150      1     6</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 4  Takiuchi 2005   40      1     6</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 5  Takiuchi 2005   60      0     3</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 6  Takiuchi 2005   80      0     4</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 7  Takiuchi 2005  100      3     6</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 8  Inokuchi 2006   70      0     3</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 9  Inokuchi 2006   80     10    42</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 10 Inokuchi 2006   90      0     3</span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="co"># illustrate data</span></span></span>
<span class="r-in"><span><span class="fu"><a href="https://rdrr.io/r/graphics/plot.default.html" class="external-link">plot</a></span><span class="op">(</span><span class="cn">NA</span>, xlim<span class="op">=</span><span class="fu"><a href="https://rdrr.io/r/base/range.html" class="external-link">range</a></span><span class="op">(</span><span class="va">dat.roever2022</span><span class="op">$</span><span class="va">dose</span><span class="op">)</span>, ylim<span class="op">=</span><span class="fl">0</span><span class="op">:</span><span class="fl">1</span>,</span></span>
<span class="r-in"><span>     xlab<span class="op">=</span><span class="st">"dose (mg / m²)"</span>, ylab<span class="op">=</span><span class="st">"proportion"</span>,</span></span>
<span class="r-in"><span>     main<span class="op">=</span><span class="st">"dat.roever2022 (Irinotecan / S-1 data)"</span><span class="op">)</span></span></span>
<span class="r-in"><span><span class="va">studylab</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/r/base/unique.html" class="external-link">unique</a></span><span class="op">(</span><span class="va">dat.roever2022</span><span class="op">$</span><span class="va">study</span><span class="op">)</span></span></span>
<span class="r-in"><span><span class="va">colvec</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/r/grDevices/palettes.html" class="external-link">rainbow</a></span><span class="op">(</span><span class="fu"><a href="https://rdrr.io/r/base/length.html" class="external-link">length</a></span><span class="op">(</span><span class="va">studylab</span><span class="op">)</span><span class="op">)</span></span></span>
<span class="r-in"><span><span class="kw">for</span> <span class="op">(</span><span class="va">i</span> <span class="kw">in</span> <span class="fl">1</span><span class="op">:</span><span class="fu"><a href="https://rdrr.io/r/base/length.html" class="external-link">length</a></span><span class="op">(</span><span class="va">studylab</span><span class="op">)</span><span class="op">)</span> <span class="op">{</span></span></span>
<span class="r-in"><span>  <span class="va">idx</span> <span class="op">&lt;-</span> <span class="op">(</span><span class="va">dat.roever2022</span><span class="op">$</span><span class="va">study</span> <span class="op">==</span> <span class="va">studylab</span><span class="op">[</span><span class="va">i</span><span class="op">]</span><span class="op">)</span></span></span>
<span class="r-in"><span>  <span class="fu"><a href="https://rdrr.io/r/graphics/lines.html" class="external-link">lines</a></span><span class="op">(</span><span class="va">dat.roever2022</span><span class="op">[</span><span class="va">idx</span>,<span class="st">"dose"</span><span class="op">]</span>,</span></span>
<span class="r-in"><span>        <span class="va">dat.roever2022</span><span class="op">[</span><span class="va">idx</span>,<span class="st">"events"</span><span class="op">]</span> <span class="op">/</span> <span class="va">dat.roever2022</span><span class="op">[</span><span class="va">idx</span>,<span class="st">"total"</span><span class="op">]</span>,</span></span>
<span class="r-in"><span>        col<span class="op">=</span><span class="va">colvec</span><span class="op">[</span><span class="va">i</span><span class="op">]</span>, type<span class="op">=</span><span class="st">"b"</span><span class="op">)</span></span></span>
<span class="r-in"><span><span class="op">}</span></span></span>
<span class="r-in"><span><span class="fu"><a href="https://rdrr.io/r/graphics/legend.html" class="external-link">legend</a></span><span class="op">(</span><span class="st">"topleft"</span>, <span class="va">studylab</span>, col<span class="op">=</span><span class="va">colvec</span>, pch<span class="op">=</span><span class="fl">15</span><span class="op">)</span></span></span>
<span class="r-plt img"><img src="dat.roever2022-1.png" alt="" width="1728" height="1536"></span>
</code></pre></div>
    </div>
  </div>
  <div class="col-md-3 hidden-xs hidden-sm" id="pkgdown-sidebar">
    <nav id="toc" data-toggle="toc" class="sticky-top"><h2 data-toc-skip>Contents</h2>
    </nav></div>
</div>


      <footer><div class="copyright">
  <p></p><p>Developed by Wolfgang Viechtbauer, Thomas White, Daniel Noble, Alistair Senior, W. Kyle Hamilton.</p>
</div>

<div class="pkgdown">
  <p></p><p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.2.0.</p>
  <p class="preferably">Using <a href="https://preferably.amirmasoudabdol.name/?source=footer" class="external-link">preferably</a> template.</p>
</div>

      </footer></div>


<script src="https://cdnjs.cloudflare.com/ajax/libs/docsearch.js/2.6.1/docsearch.min.js" integrity="sha256-GKvGqXDznoRYHCwKXGnuchvKSwmx9SRMrZOTh2g4Sb0=" crossorigin="anonymous"></script><script>
  docsearch({
    appId: 'B3DHC2OOU8',

    apiKey: '8c74dd1e0cd05800bf9f222777e07625',
    indexName: 'wviechtb-metadat',
    inputSelector: 'input#search-input.form-control',
    transformData: function(hits) {
      return hits.map(function (hit) {
        hit.url = updateHitURL(hit);
        return hit;
      });
    }
  });
</script></body></html>

